Found 150 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is S  [Clear All Filters]
2022
Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R.  2022.  Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.. Inflamm Bowel Dis.
2023
Hill AA, Kim M, Zegarra-Ruiz DF, Chang L-C, Norwood K, Assié A, Wu W-JH, Renfroe MC, Song HWong, Major AM et al..  2023.  Acute high-fat diet impairs macrophage-supported intestinal damage resolution.. JCI Insight. 8(3)
Hill AA, Kim M, Zegarra-Ruiz DF, Chang L-C, Norwood K, Assié A, Wu W-JH, Renfroe MC, Song HWong, Major AM et al..  2023.  Acute high-fat diet impairs macrophage-supported intestinal damage resolution.. JCI Insight. 8(3)
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)
Topczewska PM, Rompe ZA, Jakob MO, Stamm A, Leclère PS, Preußer A, Duerr CU, Thole LMarie Laur, Kotsch K, Artis D et al..  2023.  ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.. Front Immunol. 14:1130933.
Rajan A, Pan Y, Mahtani P, Niec R, Longman R, Gerber J, Lukin D, Scherl E, Battat R.  2023.  The Impact of Confounders on Symptom-Endoscopic Discordances in Crohn's Disease.. Crohns Colitis 360. 5(2):otad017.
Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)
Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)
Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, Deniz Y, Rowe P, Cyr S.  2023.  Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases.. J Allergy Clin Immunol.
Smith ES, Chen J, Pan Y, Mahtani P, Lukin D, Ahmed W, Longman R, Burakoff R, Scherl E, Battat R.  2023.  The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.. J Clin Gastroenterol.
Smith ES, Chen J, Pan Y, Mahtani P, Lukin D, Ahmed W, Longman R, Burakoff R, Scherl E, Battat R.  2023.  The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.. J Clin Gastroenterol.
Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R.  2023.  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.. Inflamm Bowel Dis. 29(9):1499-1503.
Chen K, Chen J, Smith E, Mathani P, Longman R, Lukin D, Scherl E, Gerber J, Battat R.  2023.  Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease.. Inflamm Bowel Dis. 29(9):1499-1503.
Venturelli OS, Wang HH, Estrela S, Huang KCasey, Ledesma-Amaro R, Fedorec AJH, Stecher B, Lawson CE, Zarrinpar A, Guo C-J et al..  2023.  What is the key challenge in engineering microbiomes? Cell Syst. 14(2):85-90.
Venturelli OS, Wang HH, Estrela S, Huang KCasey, Ledesma-Amaro R, Fedorec AJH, Stecher B, Lawson CE, Zarrinpar A, Guo C-J et al..  2023.  What is the key challenge in engineering microbiomes? Cell Syst. 14(2):85-90.
2024
Abramson J, Dobeš J, Lyu M, Sonnenberg GF.  2024.  The emerging family of RORγt+ antigen-presenting cells.. Nat Rev Immunol. 24(1):64-77.